• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Clinical Citations: Pneumonia: A red flag for a serious comorbidity

Publication
Article
The Journal of Respiratory DiseasesThe Journal of Respiratory Diseases Vol 5 No 11
Volume 5
Issue 11

The initial evaluation of a patient with community-acquired pneumonia (CAP) should include a careful search for comorbidities, according to a study by Falguera and associates.

The initial evaluation of a patient with community-acquired pneumonia (CAP) should include a careful search for comorbidities, according to a study by Falguera and associates.

The study included 600 patients with CAP, 80% of whom were hospitalized. Underlying diseases had been documented previously in 45% of the patients. One or more new comorbid conditions were identified during the study in 6% of patients. The most common newly recognized comorbidities were diabetes, malignancy, chronic obstructive pulmonary disease, and HIV infection.

The patients who had new comorbidities were more likely than the others to have bacterial CAP and positive blood cultures, and they were more likely to require hospitalization.

The authors say that their findings are a reminder that CAP can be the first manifestation of an underlying disease, and they recommend that patients with CAP have an extensive evaluation directed at detecting comorbidities.

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Infectious disease specialist talks about COVID-19 vaccine development
Related Content
© 2024 MJH Life Sciences

All rights reserved.